According to online reports, Hong Kong-listed company Pilot Pharmaceutical Biotechnology Co., Ltd.(00399) announced that it has signed a memorandum of understanding and plans to acquire the entire equity of a target company, provided that the target company completes the acquisition of Conflux blockchain-related assets. The acquisition consideration will be paid in cash, company shares or convertible bonds, and the specific amount is to be determined. The memorandum of understanding is valid for 12 months, during which the seller is not allowed to negotiate with third parties regarding the equity of the target company. The move aims to help Pilot Pharmaceutical expand its blockchain technology business, diversify its business and find new profitable growth points. The transaction still needs to be signed before it can be implemented.